DroneShield's Split Personality: Wall Street Heavyweights Buy While Short Sellers Circle

DroneShield's revenue jumps 74% to A$125.77M, but net loss of A$32.23M and an ASIC probe weigh on shares, down 71% from peak.

The Australian counter-drone specialist is living two lives at once. One is a company posting 74 percent revenue growth, a swelling order book, and a quiet shift toward recurring income. The other is a business nursing a A$32 million net loss, an open regulatory inquiry, and a share price that has shed roughly 71 percent from its October peak. Both versions of DroneShield are real — and the market cannot seem to decide which one to believe.

The Bull-Bear Collision

That indecision was on full display in early August, when JPMorgan Chase and Citigroup each disclosed stakes of more than five percent in the company, according to market reports citing mandatory voting-rights filings. The stock jumped on August 4 after news of JPMorgan's increased position broke. Yet at virtually the same moment, DroneShield was flagged as the most shorted stock on the Australian market, based on ASIC data.

Rarely do such contradictory signals arrive in the same breath. Aggressive short bets on one side, two Wall Street titans building positions on the other — it is a market that has fundamentally different views on where this story goes.

The skepticism is understandable. The company's half-year results, released on Wednesday, show a business investing heavily before demand has fully justified the spending. Headcount swelled to 535 employees by June 30, up 172 people year-on-year, driving personnel costs 165 percent higher to A$56.1 million. Revenue climbed to A$125.77 million from A$72.32 million in the prior-year period, but the bottom line flipped from a A$2.12 million net profit to a A$32.23 million net loss. The cash position, while still comfortable at A$180 million with no debt, has shrunk from A$210.6 million at the end of the last fiscal year — the money visibly flowing into raw materials and research, the very capacity future orders will need.

The Backlog Argument

For the optimists, the counterargument sits in the committed revenue figure of A$240.4 million as of August 21, including A$43 million slated for 2027 and beyond. Management reaffirmed its full-year guidance of A$250 million to A$270 million in revenue on that basis. A company with that kind of visibility into future earnings does not, on the face of it, deserve a sell-off mentality.

Nor should the quieter transformation in the business model be overlooked. Recurring software and subscription revenue jumped 229 percent to A$11.5 million, backed by more than 4,100 active software-enabled devices worldwide. That still represents just 9.2 percent of total revenue, up from A$3.5 million in the prior-year period, but it marks a structural shift for a company long viewed as a lumpy project-based contractor. Recurring revenue makes the model more predictable and less dependent on individual large orders.

The market, however, has not been in a forgiving mood. Bell Potter trimmed its price target by 4 percent to A$2.40 about a month ago, maintaining a buy rating but citing the sharply higher cost base that produced a significant earnings miss despite revenue meeting expectations. The stock has cooled further since.

A Product Launch That Fell Flat

DroneShield also brought a new product to market roughly three weeks ago: RfRecon, a portable signals-intelligence device aimed at defense, security, and government customers. Since the unveiling, the shares have lost 18.5 percent — a sign that the market now greets product announcements with skepticism rather than reflexive enthusiasm.

The chart tells the story of a stock caught between extremes. Friday's close of EUR 1.08 left the shares down 0.7 percent on the day and roughly 71 percent below the 52-week high of EUR 3.79 reached in early October. Yet they still trade 32 percent above the 52-week low of EUR 0.8230 set in late November. The stock sits 18 percent below its 50-day moving average — a market that plainly distrusts the operational growth story while the losses and the open question hang over it.

The Regulatory Shadow

That open question is the Australian Securities and Investments Commission's ongoing investigation, which continues without new findings. The company is cooperating, but the case remains unresolved — an uncertainty that cannot be captured in financial metrics and one that keeps institutional investors on edge until clarity arrives.

The reported loss stems from higher spending on production capacity and internal systems — the price of growth, arguably, rather than a warning sign. But it is also precisely the kind of number that makes short-term-oriented investors nervous.

What emerges is a company stretched between structural opportunity and self-inflicted uncertainty. The order book is growing, the software business is compounding, costs are climbing in tandem — and the regulatory question remains unanswered. For a business that lives on trust, both from government customers and capital providers, the coming months will test whether the fundamental progress can eventually outweigh the market's doubts. The presence of JPMorgan and Citigroup suggests some of the smartest money on Wall Street is betting it will.